385 related articles for article (PubMed ID: 29493812)
1. BET proteins in abnormal metabolism, inflammation, and the breast cancer microenvironment.
Andrieu GP; Shafran JS; Deeney JT; Bharadwaj KR; Rangarajan A; Denis GV
J Leukoc Biol; 2018 Aug; 104(2):265-274. PubMed ID: 29493812
[TBL] [Abstract][Full Text] [Related]
2. BET Proteins Exhibit Transcriptional and Functional Opposition in the Epithelial-to-Mesenchymal Transition.
Andrieu GP; Denis GV
Mol Cancer Res; 2018 Apr; 16(4):580-586. PubMed ID: 29437854
[TBL] [Abstract][Full Text] [Related]
3. The crosstalk within the breast tumor microenvironment in type II diabetes: Implications for cancer disparities.
Ennis CS; Llevenes P; Qiu Y; Dries R; Denis GV
Front Endocrinol (Lausanne); 2022; 13():1044670. PubMed ID: 36531496
[TBL] [Abstract][Full Text] [Related]
4. Altered regulation and expression of genes by BET family of proteins in COPD patients.
Malhotra R; Kurian N; Zhou XH; Jiang F; Monkley S; DeMicco A; Clausen IG; Dellgren G; Edenro G; Ahdesmäki MJ; Clausen M; Öberg L; Israelsson E; Belfield G; Vaarala O
PLoS One; 2017; 12(3):e0173115. PubMed ID: 28248992
[TBL] [Abstract][Full Text] [Related]
5. Tumoral BRD4 expression in lymph node-negative breast cancer: association with T-bet+ tumor-infiltrating lymphocytes and disease-free survival.
Lee M; Tayyari F; Pinnaduwage D; Bayani J; Bartlett JMS; Mulligan AM; Bull SB; Andrulis IL
BMC Cancer; 2018 Jul; 18(1):750. PubMed ID: 30029633
[TBL] [Abstract][Full Text] [Related]
6. Understanding the mechanisms underlying obesity in remodeling the breast tumor immune microenvironment: from the perspective of inflammation.
Zhang H; Wang M; Xu Y
Cancer Biol Med; 2023 Mar; 20(4):268-86. PubMed ID: 36880535
[TBL] [Abstract][Full Text] [Related]
7. Systematic analysis of the BET family in adrenocortical carcinoma: The expression, prognosis, gene regulation network, and regulation targets.
Situ Y; Liang Q; Zeng Z; Chen J; Shao Z; Xu Q; Lu X; Cui Y; Zhang J; Lu L; Deng L
Front Endocrinol (Lausanne); 2023; 14():1089531. PubMed ID: 36793283
[TBL] [Abstract][Full Text] [Related]
8. BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses.
Belkina AC; Nikolajczyk BS; Denis GV
J Immunol; 2013 Apr; 190(7):3670-8. PubMed ID: 23420887
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4.
Dai X; Gan W; Li X; Wang S; Zhang W; Huang L; Liu S; Zhong Q; Guo J; Zhang J; Chen T; Shimizu K; Beca F; Blattner M; Vasudevan D; Buckley DL; Qi J; Buser L; Liu P; Inuzuka H; Beck AH; Wang L; Wild PJ; Garraway LA; Rubin MA; Barbieri CE; Wong KK; Muthuswamy SK; Huang J; Chen Y; Bradner JE; Wei W
Nat Med; 2017 Sep; 23(9):1063-1071. PubMed ID: 28805820
[TBL] [Abstract][Full Text] [Related]
10. The mechanisms behind the therapeutic activity of BET bromodomain inhibition.
Shi J; Vakoc CR
Mol Cell; 2014 Jun; 54(5):728-36. PubMed ID: 24905006
[TBL] [Abstract][Full Text] [Related]
11. Recruitment of Brd3 and Brd4 to acetylated chromatin is essential for proinflammatory cytokine-induced matrix-degrading enzyme expression.
Dai J; Zhou S; Ge Q; Qin J; Li J; Ju H; Cao Y; Zheng M; Li C; Gao X; Teng H; Jiang Q
J Orthop Surg Res; 2019 Feb; 14(1):59. PubMed ID: 30786900
[TBL] [Abstract][Full Text] [Related]
12. BET inhibitors block pancreatic stellate cell collagen I production and attenuate fibrosis in vivo.
Kumar K; DeCant BT; Grippo PJ; Hwang RF; Bentrem DJ; Ebine K; Munshi HG
JCI Insight; 2017 Feb; 2(3):e88032. PubMed ID: 28194432
[TBL] [Abstract][Full Text] [Related]
13. Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation.
Zhang P; Wang D; Zhao Y; Ren S; Gao K; Ye Z; Wang S; Pan CW; Zhu Y; Yan Y; Yang Y; Wu D; He Y; Zhang J; Lu D; Liu X; Yu L; Zhao S; Li Y; Lin D; Wang Y; Wang L; Chen Y; Sun Y; Wang C; Huang H
Nat Med; 2017 Sep; 23(9):1055-1062. PubMed ID: 28805822
[TBL] [Abstract][Full Text] [Related]
14. Similarities and Distinctions of Cancer and Immune Metabolism in Inflammation and Tumors.
Andrejeva G; Rathmell JC
Cell Metab; 2017 Jul; 26(1):49-70. PubMed ID: 28683294
[TBL] [Abstract][Full Text] [Related]
15. Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors.
Janouskova H; El Tekle G; Bellini E; Udeshi ND; Rinaldi A; Ulbricht A; Bernasocchi T; Civenni G; Losa M; Svinkina T; Bielski CM; Kryukov GV; Cascione L; Napoli S; Enchev RI; Mutch DG; Carney ME; Berchuck A; Winterhoff BJN; Broaddus RR; Schraml P; Moch H; Bertoni F; Catapano CV; Peter M; Carr SA; Garraway LA; Wild PJ; Theurillat JP
Nat Med; 2017 Sep; 23(9):1046-1054. PubMed ID: 28805821
[TBL] [Abstract][Full Text] [Related]
16. Brd4 is essential for IL-1β-induced inflammation in human airway epithelial cells.
Khan YM; Kirkham P; Barnes PJ; Adcock IM
PLoS One; 2014; 9(4):e95051. PubMed ID: 24759736
[TBL] [Abstract][Full Text] [Related]
17. Regulation of NO synthesis, local inflammation, and innate immunity to pathogens by BET family proteins.
Wienerroither S; Rauch I; Rosebrock F; Jamieson AM; Bradner J; Muhar M; Zuber J; Müller M; Decker T
Mol Cell Biol; 2014 Feb; 34(3):415-27. PubMed ID: 24248598
[TBL] [Abstract][Full Text] [Related]
18. Metabolic pathways in obesity-related breast cancer.
Brown KA
Nat Rev Endocrinol; 2021 Jun; 17(6):350-363. PubMed ID: 33927368
[TBL] [Abstract][Full Text] [Related]
19. WHAT do viruses BET on?
Weidner-Glunde M; Ottinger M; Schulz TF
Front Biosci (Landmark Ed); 2010 Jan; 15(2):537-49. PubMed ID: 20036832
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a Small-Molecule Degrader of Bromodomain and Extra-Terminal (BET) Proteins with Picomolar Cellular Potencies and Capable of Achieving Tumor Regression.
Zhou B; Hu J; Xu F; Chen Z; Bai L; Fernandez-Salas E; Lin M; Liu L; Yang CY; Zhao Y; McEachern D; Przybranowski S; Wen B; Sun D; Wang S
J Med Chem; 2018 Jan; 61(2):462-481. PubMed ID: 28339196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
